The Priority Review

Tag

IMpower030

1 story

  1. Clinical trials

    Hoffmann-La Roche posts results of Phase 3 IMpower030 atezolizumab trial in resectable NSCLC

    Results for the IMpower030 study were first posted on ClinicalTrials.gov on October 9, 2026. The Phase 3 trial enrolled 453 participants and completed primary data collection on October 1, 2025.